请选择 进入手机版 | 继续访问电脑版

搜索

视点 | 新乙肝指南再“cue”积极治疗乙肝,降低肝癌风险要不遗余力 ... ...

2020-3-17 18:12 /来自: 国际肝病



参考文献:


1.中华医学会感染病学分会,中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版). 临床肝胆病杂志. 临床肝胆病杂志, 2019, 35(12): 2648 -2669.


2.Zhou M1, Wang H2, Zeng X1, Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019 Sep 28;394(10204):1145-1158. 


3.Wang MJ, Wang YT, Feng XS, et al. Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China north areas: Experience of the Chinese National Cancer Center. Int J Infect Dis.  2017;65:15-21.


4.Choi J, Kim HJ, Lee J, et al. Risk of hepatocellular carcinoma in patients treated with entecavir vs tenofovir for chronic hepatitis B: A Korean nationwide cohort study. JAMA Oncol 2019;5:30–36.


5.Murata K, Asano M, Matsumoto A, et al. Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection. Gut 2018; 67: 362-71.


6.Murata K, et al. Immunomodulatory mechanism of acyclic nucleoside phosphates in treatment of hepatitis B virus infection. Hepatology. 2019 Sep 17. doi: 10.1002/hep.30956


12
返回顶部